Disclosing the potential of eleganolone for Parkinson’s disease therapeutics: neuroprotective and anti-inflammatory activities
The treatment of Parkinson´s disease (PD) has benefited from significant advances resulting from the increasing research efforts focused on new therapeutics. However, the current treatments for PD are mostly symptomatic, alleviating disease symptoms without reversing or retarding disease progression...
Main Author: | |
---|---|
Other Authors: | , , , , , , , , , , |
Format: | article |
Language: | eng |
Published: |
2021
|
Subjects: | |
Online Access: | http://hdl.handle.net/10400.8/5996 |
Country: | Portugal |
Oai: | oai:iconline.ipleiria.pt:10400.8/5996 |